Pathogenic Bacteria: Genomics, Virulence Factors, and Antibiotic Resistance
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanism and Evolution of Antibiotic Resistance".
Deadline for manuscript submissions: closed (31 January 2023) | Viewed by 10261
Special Issue Editor
Interests: resistant mechanism of multi-drug resistant bacteria; molecular epidemiology of multi-drug resistance; diagnosis of infectious diseases
Special Issue Information
Dear Colleagues,
Pathogenic bacteria induce various diseases, such as intestinal infection, urinary tract infection, pneumonia, and even systemic infection, which cause significant harm to human health. Without effective control, bacterial infection will become the most important cause of death worldwide. Effective treatment and prevention of bacterial infections are essential to human health, and scientific research is the foundation of our defense against bacterial infection. In recent years, research on pathogenic bacteria has mainly included investigating bacterial drug resistance, bacterial virulence, and bacterial genomics in various circumstances. Clinical treatment and drug development depend on the mechanism studies of bacterial drug resistance and the function of their virulence factors. Along with developing the whole-genome sequencing technique, bacterial genomics studies significantly benefit pathogenic bacteria investigations. Overall, this Special Issue of Antibiotics aims to highlight recent findings in our knowledge of pathogenic bacteria studies, including genomics, virulence factors, and antibiotic resistance, and contributors are encouraged to provide original research papers or reviews in the related fields.
Prof. Dr. Yunsong Yu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pathogenic bacteria
- drug resistance
- virulence
- genomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.